Iloprost treatment in pediatric patients with complicated Raynaud's phenomenon

Lupus. 2016 Apr;25(5):558-60. doi: 10.1177/0961203315622898. Epub 2015 Dec 21.

Authors

S Cekic¹, S S Kilic²

Affiliations

¹ Uludag University Faculty of Medicine Division of Pediatric Immunology and Rheumatology, Uludag University School of Medicine, Bursa, Turkey drsukrucekic@gmail.com.
² Uludag University Faculty of Medicine Division of Pediatric Immunology and Rheumatology, Uludag University School of Medicine, Bursa, Turkey.

PMID: 26692039
DOI: 10.1177/0961203315622898

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adolescent
Age of Onset
Antiphospholipid Syndrome / complications*
Antiphospholipid Syndrome / diagnosis
Child
Female
Foot / blood supply*
Foot Ulcer / etiology
Humans
Iloprost / therapeutic use*
Ischemia / diagnosis
Ischemia / drug therapy*
Ischemia / etiology
Ischemia / physiopathology
Raynaud Disease / diagnosis
Raynaud Disease / drug therapy*
Raynaud Disease / etiology
Raynaud Disease / physiopathology
Regional Blood Flow
Treatment Outcome
Vasoconstriction / drug effects*
Vasodilator Agents / therapeutic use*
Wound Healing / drug effects

Substances

Vasodilator Agents
Iloprost